{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:09:28Z","timestamp":1788898168732,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300674"],"award-info":[{"award-number":["82300674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.steroids.2026.109850","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:44:37Z","timestamp":1788698677000},"page":"109850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of ER-\u03b136 and RUNX2 interaction in breast cancer progression"],"prefix":"10.1016","volume":"235-236","author":[{"given":"Jia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.steroids.2026.109850_bb0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2024.02.002","article-title":"Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities","volume":"45","author":"Chen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.steroids.2026.109850_bb0010","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/djae056","article-title":"The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis","volume":"116","author":"Kumar","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.steroids.2026.109850_bb0015","article-title":"HTR1A inhibits the progression of triple-negative breast Cancer via TGF-beta canonical and noncanonical pathways","volume":"9","author":"Liu","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.steroids.2026.109850_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-022-01362-9","article-title":"Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.steroids.2026.109850_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184408","article-title":"MET oncogene controls invasive growth by coupling with NMDA receptor","volume":"14","author":"Gallo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.steroids.2026.109850_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-022-01514-2","article-title":"Breast cancer metastasis to brain results in recruitment and activation of microglia through annexin-A1\/formyl peptide receptor signaling","volume":"24","author":"Foo","year":"2022","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.steroids.2026.109850_bb0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbrc.2005.08.226","article-title":"Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66","volume":"336","author":"Wang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2026.109850_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.922110","article-title":"Inhibitors targeting multiple Janus kinases from Zanthoxylum simulans mediate inhibition and apoptosis against gastric Cancer cells via the estrogen pathway","volume":"10","author":"Tian","year":"2022","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.steroids.2026.109850_bb0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbrc.2017.04.105","article-title":"ER-alpha36 mediates estrogen-stimulated MAPK\/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells","volume":"487","author":"Sun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2026.109850_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106523","article-title":"Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer","volume":"241","author":"Abbas","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2026.109850_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cas.13868","article-title":"Estrogen receptor variant ER-alpha36 promotes tamoxifen agonist activity in glioblastoma cells","volume":"110","author":"Qu","year":"2019","journal-title":"Cancer Sci."},{"issue":"3\u20135","key":"10.1016\/j.steroids.2026.109850_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jsbmb.2011.08.004","article-title":"Advances in the understanding of the structure and function of ER-alpha36, a novel variant of human estrogen receptor-alpha","volume":"127","author":"Rao","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.steroids.2026.109850_bb0065","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1541-7786.MCR-23-0321","article-title":"Progress in the understanding of estrogen receptor alpha signaling in triple-negative breast Cancer: reactivation of silenced ER-alpha and signaling through ER-alpha36","volume":"21","author":"Al-Kabariti","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.steroids.2026.109850_bb0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12033-023-01029-x","article-title":"Expression significance of estrogen receptor ER-alpha36 in breast Cancer treated by chemotherapy: a Meta-analysis","volume":"66","author":"He","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"8","key":"10.1016\/j.steroids.2026.109850_bb0075","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.febslet.2009.03.047","article-title":"Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36","volume":"583","author":"Zou","year":"2009","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.steroids.2026.109850_bb0080","first-page":"2604","article-title":"Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-alpha36","volume":"39","author":"Shen","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.steroids.2026.109850_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.steroids.2018.02.007","article-title":"The ER-alpha36\/EGFR signaling loop promotes growth of hepatocellular carcinoma cells","volume":"134","author":"You","year":"2018","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.steroids.2026.109850_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.steroids.2012.02.013","article-title":"Estrogen-independent effects of ER-alpha36 in ER-negative breast cancer","volume":"77","author":"Zhang","year":"2012","journal-title":"Steroids"},{"issue":"3\u20135","key":"10.1016\/j.steroids.2026.109850_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jsbmb.2011.08.011","article-title":"A positive cross-regulation of HER2 and ER-alpha36 controls ALDH1 positive breast cancer cells","volume":"127","author":"Kang","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.steroids.2026.109850_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00018-013-1440-z","article-title":"Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology","volume":"71","author":"Berendsen","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.steroids.2026.109850_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41416-026-03439-5","article-title":"Runx1 and Runx2 act in concert to suppress Wnt\/beta-catenin-driven mammary tumourigenesis","volume":"135","author":"Riggio","year":"2026","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.steroids.2026.109850_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114701","article-title":"Injectable hydrogel induces tumor cell extracellular calcification and bone regeneration to disrupt the osteolytic vicious cycle in bone metastasis","volume":"392","author":"Lin","year":"2026","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.steroids.2026.109850_bb0115","doi-asserted-by":"crossref","first-page":"20969","DOI":"10.3390\/ijms160920969","article-title":"Role of RUNX2 in breast carcinogenesis","volume":"16","author":"Wysokinski","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2026.109850_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bcmd.2010.05.007","article-title":"Runx2 in normal tissues and cancer cells: a developing story","volume":"45","author":"Blyth","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"issue":"44","key":"10.1016\/j.steroids.2026.109850_bb0125","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M306531200","article-title":"Runx2 integrates estrogen activity in osteoblasts","volume":"278","author":"McCarthy","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.steroids.2026.109850_bb0130","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.ejca.2009.06.021","article-title":"Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer","volume":"45","author":"Das","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.steroids.2026.109850_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12253-015-0018-5","article-title":"Runx2 expression as a potential prognostic marker in invasive ductal breast carcinoma","volume":"22","author":"El-Gendi","year":"2016","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.steroids.2026.109850_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s11427-010-0100-x","article-title":"Caveolin-1 gene silencing promotes the activation of PI3K\/AKT dependent on Eralpha36 and the transformation of MCF10ACE","volume":"53","author":"Feng","year":"2010","journal-title":"Sci. China Life Sci."},{"issue":"3","key":"10.1016\/j.steroids.2026.109850_bb0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbrc.2014.09.111","article-title":"The temporal expression of estrogen receptor alpha-36 and runx2 in human bone marrow derived stromal cells during osteogenesis","volume":"453","author":"Francis","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6C","key":"10.1016\/j.steroids.2026.109850_bb0150","first-page":"4581","article-title":"Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells","volume":"23","author":"Zou","year":"2003","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.steroids.2026.109850_bb0155","first-page":"521","article-title":"Optimization of method for detecting the activation of potassium channels in rat cardiac muscle cells","volume":"24","author":"Wang","year":"2008","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"18","key":"10.1016\/j.steroids.2026.109850_bb0160","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/0008-5472.CAN-14-0053","article-title":"Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer","volume":"74","author":"Owens","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.steroids.2026.109850_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41413-025-00439-8","article-title":"Membrane-initiated estrogen receptor-alpha signaling in osteoblasts is crucial for normal regulation of the cortical bone in female mice","volume":"13","author":"Jiang","year":"2025","journal-title":"Bone Res."},{"issue":"4","key":"10.1016\/j.steroids.2026.109850_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040641","article-title":"The RUNX\/CBFbeta complex in breast cancer: a conundrum of context","volume":"12","author":"Khan","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.steroids.2026.109850_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12013-014-0163-6","article-title":"Expression and localization of estrogen receptor in human breast cancer and its clinical significance","volume":"71","author":"Li","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"26","key":"10.1016\/j.steroids.2026.109850_bb0180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001048","article-title":"High ERalpha36 expression level and membrane location predict poor prognosis in renal cell carcinoma","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.steroids.2026.109850_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109224","article-title":"The location of estrogen receptor variant ER-alpha36 is associated with the invasion of glioblastoma","volume":"194","author":"Li","year":"2023","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.steroids.2026.109850_bb0190","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1349-7006.2010.01742.x","article-title":"Runx2 in human breast carcinoma: its potential roles in cancer progression","volume":"101","author":"Onodera","year":"2010","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.steroids.2026.109850_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jcp.20469","article-title":"Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2","volume":"206","author":"Pockwinse","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.steroids.2026.109850_bb0200","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1210\/en.2008-0680","article-title":"Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer","volume":"149","author":"Khalid","year":"2008","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.steroids.2026.109850_bb0205","first-page":"2057","article-title":"Minireview: genomic organization of the human ERalpha gene promoter region","volume":"15","author":"Kos","year":"2001","journal-title":"Mol. Endocrinol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:01:29Z","timestamp":1788897689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X26001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0039128X26001121"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109850","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of ER-\u03b136 and RUNX2 interaction in breast cancer progression","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109850"}}